These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 26891240

  • 1. Olfactory bulbectomy-induced changes in phospholipids and protein profiles in the hippocampus and prefrontal cortex of rats. A preliminary study using a FTIR spectroscopy.
    Depciuch J, Sowa-Kućma M, Misztak P, Szewczyk B, Nowak G, Pankiewicz P, Parlińska-Wojtan M.
    Pharmacol Rep; 2016 Jun; 68(3):521-8. PubMed ID: 26891240
    [Abstract] [Full Text] [Related]

  • 2. Qualitative and quantitative changes in phospholipids and proteins investigated by spectroscopic techniques in olfactory bulbectomy animal depression model.
    Depciuch J, Parlinska-Wojtan M.
    J Pharm Biomed Anal; 2018 Jan 30; 148():24-31. PubMed ID: 28950213
    [Abstract] [Full Text] [Related]

  • 3. The role of zinc deficiency-induced changes in the phospholipid-protein balance of blood serum in animal depression model by Raman, FTIR and UV-vis spectroscopy.
    Depciuch J, Sowa-Kućma M, Nowak G, Szewczyk B, Doboszewska U, Parlinska-Wojtan M.
    Biomed Pharmacother; 2017 May 30; 89():549-558. PubMed ID: 28258037
    [Abstract] [Full Text] [Related]

  • 4. Olfactory bulbectomy and amitriptyline treatment influences mGlu receptors expression in the mouse brain hippocampus.
    Wierońska JM, Legutko B, Dudys D, Pilc A.
    Pharmacol Rep; 2008 May 30; 60(6):844-55. PubMed ID: 19211976
    [Abstract] [Full Text] [Related]

  • 5. The level of the zinc homeostasis regulating proteins in the brain of rats subjected to olfactory bulbectomy model of depression.
    Rafalo A, Zadrozna M, Nowak B, Kotarska K, Wiatrowska K, Pochwat B, Sowa-Kucma M, Misztak P, Nowak G, Szewczyk B.
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jan 04; 72():36-48. PubMed ID: 27565434
    [Abstract] [Full Text] [Related]

  • 6. Chronic antidepressant-like effect of EMD386088, a partial 5-HT6 receptor agonist, in olfactory bulbectomy model may be connected with BDNF and/or CREB signalling pathway.
    Jastrzębska-Więsek M, Gdula-Argasińska J, Siwek A, Partyka A, Szewczyk B, Kołaczkowski M, Wesołowska A.
    Pharmacol Rep; 2018 Dec 04; 70(6):1047-1056. PubMed ID: 30292720
    [Abstract] [Full Text] [Related]

  • 7. Antidepressant-like activity of magnesium in the olfactory bulbectomy model is associated with the AMPA/BDNF pathway.
    Pochwat B, Sowa-Kucma M, Kotarska K, Misztak P, Nowak G, Szewczyk B.
    Psychopharmacology (Berl); 2015 Jan 04; 232(2):355-67. PubMed ID: 25027582
    [Abstract] [Full Text] [Related]

  • 8. Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat.
    Sairanen M, O'Leary OF, Knuuttila JE, Castrén E.
    Neuroscience; 2007 Jan 05; 144(1):368-74. PubMed ID: 17049169
    [Abstract] [Full Text] [Related]

  • 9. Brain glutamic acid decarboxylase-67kDa alterations induced by magnesium treatment in olfactory bulbectomy and chronic mild stress models in rats.
    Pochwat B, Nowak G, Szewczyk B.
    Pharmacol Rep; 2016 Oct 05; 68(5):881-5. PubMed ID: 27351943
    [Abstract] [Full Text] [Related]

  • 10. Chronic administration of amitriptyline differentially alters neuropathic pain-related behaviour in the presence and absence of a depressive-like phenotype.
    Burke NN, Finn DP, Roche M.
    Behav Brain Res; 2015 Feb 01; 278():193-201. PubMed ID: 25300472
    [Abstract] [Full Text] [Related]

  • 11. Bax inhibitor-1 overexpression in prelimbic cortex protects rats against depression-like behavior induced by olfactory bulbectomy and reduces apoptotic and inflammatory signals.
    Li D, Cai Z, Wu J, Zhang Y.
    Neurol Res; 2019 Apr 01; 41(4):369-377. PubMed ID: 30735101
    [Abstract] [Full Text] [Related]

  • 12. Region-specific dysregulation of allopregnanolone brain content in the olfactory bulbectomized rat model of depression.
    Uzunova V, Ceci M, Kohler C, Uzunov DP, Wrynn AS.
    Brain Res; 2003 Jun 20; 976(1):1-8. PubMed ID: 12763616
    [Abstract] [Full Text] [Related]

  • 13. Olfactory bulbectomy provokes a suppression of interleukin-1beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: effect of chronic desipramine treatment.
    Connor TJ, Harkin A, Kelly JP, Leonard BE.
    Neuroimmunomodulation; 2000 Jun 20; 7(1):27-35. PubMed ID: 10601816
    [Abstract] [Full Text] [Related]

  • 14. Qualitative and quantitative changes in phospholipids and proteins investigated by spectroscopic techniques in animal depression model.
    Depciuch J, Sowa-Kucma M, Nowak G, Papp M, Gruca P, Misztak P, Parlinska-Wojtan M.
    Spectrochim Acta A Mol Biomol Spectrosc; 2017 Apr 05; 176():30-37. PubMed ID: 28063309
    [Abstract] [Full Text] [Related]

  • 15. Phospholipid-protein balance in affective disorders: Analysis of human blood serum using Raman and FTIR spectroscopy. A pilot study.
    Depciuch J, Sowa-Kućma M, Nowak G, Dudek D, Siwek M, Styczeń K, Parlińska-Wojtan M.
    J Pharm Biomed Anal; 2016 Nov 30; 131():287-296. PubMed ID: 27614042
    [Abstract] [Full Text] [Related]

  • 16. Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas.
    Hellweg R, Zueger M, Fink K, Hörtnagl H, Gass P.
    Neurobiol Dis; 2007 Jan 30; 25(1):1-7. PubMed ID: 16990008
    [Abstract] [Full Text] [Related]

  • 17. Antidepressant-mediated reversal of abnormal behavior and neurodegeneration in mice following olfactory bulbectomy.
    Jarosik J, Legutko B, Unsicker K, von Bohlen Und Halbach O.
    Exp Neurol; 2007 Mar 30; 204(1):20-8. PubMed ID: 17059819
    [Abstract] [Full Text] [Related]

  • 18. Behavioural and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety.
    Wang D, Noda Y, Tsunekawa H, Zhou Y, Miyazaki M, Senzaki K, Nabeshima T.
    Behav Brain Res; 2007 Mar 28; 178(2):262-73. PubMed ID: 17261334
    [Abstract] [Full Text] [Related]

  • 19. Behavioral, neurochemical and molecular changes after acute deep brain stimulation of the infralimbic prefrontal cortex.
    Jiménez-Sánchez L, Linge R, Campa L, Valdizán EM, Pazos Á, Díaz Á, Adell A.
    Neuropharmacology; 2016 Sep 28; 108():91-102. PubMed ID: 27108934
    [Abstract] [Full Text] [Related]

  • 20. Neurochemical changes underlying cognitive impairment in olfactory bulbectomized rats and the impact of the mGlu5-positive allosteric modulator CDPPB.
    Płoska A, Cieślik P, Siekierzycka A, Kalinowski L, Wierońska JM.
    Brain Res; 2021 Oct 01; 1768():147577. PubMed ID: 34217728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.